Skip to main content
. 2022 May 20;3(5):e221116. doi: 10.1001/jamahealthforum.2022.1116

Figure 2. Projected Age-Adjusted Prostate Cancer Mortality Rates Under No Screening and Specified Screening Strategies.

Figure 2.

Mortality rates projected by the 2 models have slightly increasing or decreasing secular trends owing to different methods for modeling population counts. FHCRC indicates Fred Hutchinson Cancer Research Center; MISCAN, Erasmus Medical Center Microsimulation Screening Analysis; and PSA, prostate-specific antigen.